840 INDEX
meropenem, 550, 791
Merrem IVseemeropenem
mesenchymal stem cell injections, 164
metabolic epidermal necrosisseesuperficial necrolytic
dermatosis
Metacamseemeloxicam
methicillin resistance, 143–144, 145–146, 151–152
methicillin-resistantStaphylococcus aureus
(MRSA), 143–144, 145–146
community acquired (CA-MRSA), 145
hospital acquired (HA-MRSA), 145
infection control, 147
methicillin-resistantStaphylococcus pseudintermedius
(MRSP), 142, 143–144, 145–146,153–154
methicillin-resistantStaphylococcus schleiferi
(MRSS), 143–144, 145–146
methimazole, 792
methocarbamol, 792
methotrexate, 793
methylprednisolone,793–794
for atopic disease, 180
for autoimmune blistering diseases, 197
for eosinophilic granuloma (complex), 355
methyltestosterone, 341, 794
Meticortenseeprednisone
metoclopramide, 795
metronidazole, 164, 795
metyrapone, 411
Mexateseemethotrexate
Mexican dog, 61
mibolerone, 796
miconazole, 324
microabscesses, 40
microbiome, skin, 211–212
microneedling therapy, 341
micronychia, 588
Microsporum canis, 29, 320, 321
clinical features,326, 327–328, 330–331
culture and identification,33, 34, 334–335
diagnostics, 322
pododermatitis, 606
zoonotic potential,331, 729–730
Microsporum gypseum, 29, 320, 321
clinical features, 326
culture and identification,31, 33, 34, 334–335
milbemycin, 796
for demodicosis, 301
for sarcoptid mites, 637
toxicity, 303
milia, 13, 16
miliary dermatitis (cat)
allergic, 351, 352, 353, 354, 362
bacterial pyoderma, 213, 215, 223
flea bite hypersensitivity, 241
milk thistleseesilymarin
miltefosine, 463
miniature pinscher, 739
hypopituitary dwarfism, 338
pattern baldness, 60
sebaceous adenitis, 648
miniature poodle, 741
alopecia X, 338
cutaneous adverse drug reactions, 273
Malasseziadermatitis, 481
panniculitis, 563
miniature schnauzer, 740
acquired aurotrichia, 66
atopic disease, 175
cutaneous adverse drug reactions, 273,279–280
hypothyroidism, 417
mycobacterial infections, 511
papillomavirus infections, 713
primary seborrhea, 433
schnauzer comedo syndrome, 434, 452
skin and adnexal tumors, 673, 674
superficial suppurative necrolytic dermatitis, 274
vitamin A-responsive dermatosis, 433
Minocinseeminocycline
minocycline, 796
for claw disorders, 594
for lupus erythematosus, 471–472
for methicillin-resistant staphylococci, 152
for nocardiosis, 538
for panniculitis, 566
for pemphigus/pemphigoid, 196
for reactive cutaneous histiocytosis, 386
for sebaceous adenitis, 650
for vasculitis, 701–702
Mitabanseeamitraz
mite infestations
acetate tape preparation, 47
exfoliative dermatosis, 62, 95
external ear canal, 544,558, 634
skin scrapings, 43–44,48–49
trichograms, 44, 50
see alsocheyletiellosis; demodicosis;Notoedres cati;
Otodectes cynotis; Sarcoptes scabieivar.canis;
sarcoptid mites
mitotane, 341, 400–401, 411, 797
mitoxantrone, 679
Mobicseemeloxicam
moisturizers, 438
mosquito bite dermatitis, 240, 244, 247
clinical features, 242, 257
diagnostics, 245
mosquito bite hypersensitivity, 240, 244
clinical features, 64, 67,121,242,258–260
diagnostics, 245
eosinophilic granuloma complex, 351
therapeutics, 247
“moth-eaten” appearance, pyoderma, 214, 215, 223
Motrinseeibuprofen
moxidectin, 797
for demodicosis, 302
for otitis, 550
for sarcoptid mites, 637